Emilio Russo
Zitiert von
Zitiert von
Nonpsychotropic plant cannabinoids, cannabidivarin (CBDV) and cannabidiol (CBD), activate and desensitize transient receptor potential vanilloid 1 (TRPV1) channels in vitro …
FA Iannotti, CL Hill, A Leo, A Alhusaini, C Soubrane, E Mazzarella, ...
ACS chemical neuroscience 5 (11), 1131-1141, 2014
Phthalates: European regulation, chemistry, pharmacokinetic and related toxicity
P Ventrice, D Ventrice, E Russo, G De Sarro
Environmental toxicology and pharmacology 36 (1), 88-96, 2013
Hypericum perforatum: Pharmacokinetic, Mechanism of Action, Tolerability, and Clinical Drug–Drug Interactions
E Russo, F Scicchitano, BJ Whalley, C Mazzitello, M Ciriaco, S Esposito, ...
Phytotherapy research 28 (5), 643-655, 2014
Corticosteroid-related central nervous system side effects
M Ciriaco, P Ventrice, G Russo, M Scicchitano, G Mazzitello, ...
Journal of pharmacology & pharmacotherapeutics 4 (Suppl1), S94, 2013
mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy
E Russo, R Citraro, G Donato, C Camastra, R Iuliano, S Cuzzocrea, ...
Neuropharmacology 69, 25-36, 2013
mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis
R Citraro, A Leo, A Constanti, E Russo, G De Sarro
Pharmacological research 107, 333-343, 2016
Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist
R Gitto, ML Barreca, L De Luca, G De Sarro, G Ferreri, S Quartarone, ...
Journal of medicinal chemistry 46 (1), 197-200, 2003
Epilepsy in cerebrovascular diseases: review of experimental and clinical data with meta‐analysis of risk factors
E Ferlazzo, S Gasparini, E Beghi, C Sueri, E Russo, A Leo, A Labate, ...
Epilepsia 57 (8), 1205-1214, 2016
Targeting mast cells tryptase in tumor microenvironment: a potential antiangiogenetic strategy
M Ammendola, C Leporini, I Marech, CD Gadaleta, G Scognamillo, ...
BioMed research international 2014, 2014
The mTOR signaling pathway in the brain: focus on epilepsy and epileptogenesis
E Russo, R Citraro, A Constanti, G De Sarro
Molecular neurobiology 46 (3), 662-681, 2012
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy
E Russo, A Constanti, G Ferreri, R Citraro, G De Sarro
Neuropharmacology 46 (6), 865-878, 2004
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy
R Citraro, E Russo, F Scicchitano, CM van Rijn, D Cosco, C Avagliano, ...
Neuropharmacology 69, 115-126, 2013
Metformin and autoimmunity: a “new deal” of an old drug
F Ursini, E Russo, G Pellino, S D’Angelo, A Chiaravalloti, G De Sarro, ...
Frontiers in immunology 9, 1236, 2018
Adherence to therapy and adverse drug reactions: is there a link?
C Leporini, G De Sarro, E Russo
Expert opinion on drug safety 13 (sup1), 41-55, 2014
Comparison of the antiepileptogenic effects of an early long‐term treatment with ethosuximide or levetiracetam in a genetic animal model of absence epilepsy
E Russo, R Citraro, F Scicchitano, S De Fazio, ED Di Paola, A Constanti, ...
Epilepsia 51 (8), 1560-1569, 2010
AMPA receptor antagonists as potential anticonvulsant drugs
GD Sarro, R Gitto, E Russo, GF Ibbadu, ML Barreca, LD Luca, A Chimirri
Current topics in medicinal chemistry 5 (1), 31-42, 2005
Pharmacovigilance in Italy: an overview
C Mazzitello, S Esposito, AE De Francesco, A Capuano, E Russo, ...
Journal of pharmacology & pharmacotherapeutics 4 (Suppl1), S20, 2013
Effects of early long‐term treatment with antiepileptic drugs on development of seizures and depressive‐like behavior in a rat genetic absence epilepsy model
E Russo, R Citraro, F Scicchitano, S De Fazio, I Perrota, ED Di Paola, ...
Epilepsia 52 (7), 1341-1350, 2011
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity
E Russo, R Citraro, A Davoli, L Gallelli, ED Di Paola, G De Sarro
Neuropharmacology 64, 371-379, 2013
Anticonvulsant effects of carbenoxolone in genetically epilepsy prone rats (GEPRs)
P Gareri, D Condorelli, N Belluardo, E Russo, A Loiacono, V Barresi, ...
Neuropharmacology 47 (8), 1205-1216, 2004
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20